NCT01337479View on ClinicalTrials.gov

A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

CompletedOBSERVATIONAL
Enrollment

1,097

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Hepatitis B
Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01337479 - A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials | Biotech Hunter | Biotech Hunter